Highlights From This Issue October 3, 2019 From The Carlat Psychiatry Report Issue Links: Learning Objectives | Editorial Information | PDF of Issue Quick hits on what you’ll find in this issue.Read More
FDA Approves a Hormonal Injection for Low Libido in Women October 3, 2019 Chris Aiken, MD From The Carlat Psychiatry Report Issue Links: Learning Objectives | Editorial Information | PDF of Issue Vyleesi is FDA approved for low libido in women, but its modest benefits and significant risks give us pause.Read More
General PsychiatryKarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change EverythingRead More
General PsychiatryA Scam for Every Woman, Child, and Man: Part 21 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...Listen now
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.jpg?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
